Privacy Statement   Terms & Conditions   Sitemap  
       
 
 
 

Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
» read more

Baxter receives preparedness contract from Austrian Ministry of Health for Pandemic Influenza Vaccine
» read more

Baxter Announces Safety and Immunogenicity Results from Phase I/II Clinical Trial of Cell-Based Candidate H5N1 Pandemic Vaccine
» read more

 
 
  » find
 
 

Online Game
.
 
Baxter Vaccines Industriestrasse 67, A-1221 Wien, Tel: +43-1-20100,